Your Article Summary
See Latest ArticlesRenal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
New England Journal of Medicine, 07/02/09
Mauer M et al. - Early blockade of the renin–angiotensin system in patients with type 1 diabetes did not slow nephropathy progression but slowed the progression of retinopathy.
Related Articles
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease
Nephrology Dialysis Transplantation, 11/17/09
Relevance Score: 84%
Pseudomelanosis Duodeni: An Unusual Finding From Upper Gastrointestinal Endoscopy
Clinical Gastroenterology and Hepatology, 11/04/09
Relevance Score: 80%
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of the PPARGC1A Gene Polymorphism With Diabetic Nephropathy in an Asian Indian Population (CURES-41)
Metabolic Syndrome and Related Disorders, 11/30/09
Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy
Diabetes Research and Clinical Practice, 11/25/09
Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents
Pediatric Nephrology, 11/23/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Nebivolol Improves Renal Function in Patients Who Underwent Angioplasty due to Renal Artery Stenosis: A Pilot Study
Nephron: Clinical Practice, 12/01/09
Rasburicase improves hyperuricemia in infants with acute kidney injury
Pediatric Nephrology, 12/01/09
Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome
Pediatric Nephrology, 12/01/09